Characteristics and risk factors of major and clinically relevant non-major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism - the CATCH study

被引:0
|
作者
Kamphuisen, P. W. [1 ]
Lee, A. Y. Y. [2 ,3 ]
Meyer, G. [4 ]
Bauersachs, R. [5 ]
Janas, M. S. [6 ]
Jarner, M. F. [6 ]
Khorana, A. A. [7 ]
机构
[1] Univ Med Ctr Groningen, Dept Vasc Med, NL-9713 AV Groningen, Netherlands
[2] Univ British Columbia, Div Hematol, Vancouver, BC V5Z 1M9, Canada
[3] Vancouver Coastal Hlth, Vancouver, BC, Canada
[4] Georges Pompidou European Hosp, Resp Unit, Paris, France
[5] Darmstadt Hosp, Dept Vasc Med, Darmstadt, Germany
[6] LEO Pharma, Ballerup, Denmark
[7] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OR228
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [1] Risk factors for death and thromboembolic complications in patients with major or clinically relevant non-major bleeding while on oral anticoagulant treatment
    Franco, L.
    Becattini, C.
    Masotti, L.
    Sbrojavacca, R.
    Nitti, C.
    Cappelli, R.
    Agnelli, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 564 - 564
  • [2] Risk Factors for Major Bleeding and Clinically Relevant Non-major Bleeding in Japanese Patients Treated with Edoxaban
    Takase, Tomoki
    Ikesue, Hiroaki
    Nakagawa, Haruna
    Kinoshita, Megumi
    Muroi, Nobuyuki
    Kitai, Takeshi
    Furukawa, Yutaka
    Hashida, Tohru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (03) : 458 - 462
  • [3] Clinical Performance of Bleeding Risk Scores for Predicting Major and Clinically Relevant Non-Major Bleeding Events in Patients Receiving Oral Anticoagulant Therapy
    Burgess, Sarag
    Crown, Natalie
    Louzada, Martha L.
    Dresser, George
    Kim, Richard
    Lazo-Langner, Alejandro
    BLOOD, 2011, 118 (21) : 1001 - 1002
  • [4] Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin
    Burgess, S.
    Crown, N.
    Louzada, M. L.
    Dresser, G.
    Kim, R. B.
    Lazo-Langner, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) : 1647 - 1654
  • [5] Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism
    Catella, Judith
    Bertoletti, Laurent
    Moustafa, Fares
    Antonio Nieto, Jose
    Valle, Reina
    Maria Pedrajas, Jose
    Villalobos, Aurora
    Quere, Isabelle
    Sarlon-Bartoli, Gabrielle
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2022, 214 : 29 - 36
  • [6] Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study
    Kamphuisen, P. . W.
    Lee, A. Y. Y.
    Meyer, G.
    Bauersachs, R.
    Janas, M. S.
    Jarner, M. F.
    Khorana, A. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (06) : 1069 - 1077
  • [7] Does clinically relevant non-major bleeding in acute STEMI have a higher risk of MACE?
    Jeyaindran, S.
    Jagdeep, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1081 - 1081
  • [8] Risk of Major and Clinically Relevant Non-major (CRNM) Bleeding in Patients Prescribed Rivaroxaban in Primary Care in England
    Dhanda, S.
    Davies, M.
    Roy, D.
    Wise, L.
    Shakir, S.
    DRUG SAFETY, 2018, 41 (11) : 1130 - 1131
  • [9] Incidence of Major and Clinically-Relevant Non-major Bleeding in Patients Prescribed Rivaroxaban: Results RROM the ROSE Study
    Evans, A.
    Davies, M.
    Wise, L.
    Shakir, S.
    DRUG SAFETY, 2018, 41 (11) : 1134 - 1134
  • [10] Major and non-major clinically relevant bleeding in patients hospitalized in palliative care units: results of a French multicentre observational study
    Tardy, B.
    Chapelle, C.
    Picard, S.
    Broucker, D. D.
    Delerue, M.
    Celarier, T.
    Vassal, P.
    Ciais, J-F
    Salas, S.
    Perceau, E.
    Filbet, M.
    Guirimand, F.
    Gomas, J-M
    Decherf, C.
    Bertoletti, L.
    Guillot, A.
    Gaultier, J-B
    Akrour, M.
    Rancon, F.
    Merah, A.
    Laporte, S.
    Laporte, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 547 - 547